20-F/A: Insighta Holdings Limited Financials for FY2025

Insighta Holdings Limited's FY2025 financial statements reveal a significant increase in profit before tax, driven by substantial other income, despite a decrease in revenue from laboratory testing kits.

Summary

• Insighta Holdings Limited's financial statements for the year ended December 31, 2025, show a profit before tax of $5,804,192, an increase from $4,472,893 in 2024.
• Total comprehensive income for the year was $5,647,859, up from $4,273,984 in the previous year.
• Revenue from sales of laboratory testing kits decreased to $143,575 in 2025 from $244,218 in 2024.
• Revenue from the provision of diagnostics services was $429,672 in 2025, with no comparable figure for 2024.
• Other income significantly increased to $27,896,174 in 2025 from $32,039,344 in 2024, primarily due to bank interest income.
• Other gains and losses, net, turned positive to $4,703,654 in 2025 from a loss of $2,546,087 in 2024, largely due to a foreign exchange gain and a waiver of an amount due to a related company.
• Operating and administrative expenses increased to $26,819,214 in 2025 from $24,964,324 in 2024.
• Total assets decreased slightly to $636,137,983 as of December 31, 2025, from $637,432,339 as of December 31, 2024.
• Total liabilities significantly decreased to $6,523,284 as of December 31, 2025, from $13,465,499 as of December 31, 2024.
• Equity increased to $629,614,699 as of December 31, 2025, from $623,966,840 as of December 31, 2024.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive, with an increase in profitability driven by non-operational income and a significant reduction in liabilities, though a decline in a key revenue stream warrants attention.

Positives

• Profit before tax increased by approximately 29.7% to $5,804,192 in 2025 from $4,472,893 in 2024.
• Total comprehensive income increased by approximately 32.1% to $5,647,859 in 2025 from $4,273,984 in 2024.
• Other income, primarily driven by bank interest income, remained strong at $27,896,174 in 2025.
• The company achieved a net gain of $4,703,654 from other gains and losses in 2025, a significant turnaround from a net loss of $2,546,087 in 2024, boosted by foreign exchange gains and a waiver of debt from a related company.
• Total liabilities were significantly reduced by approximately 51.5% to $6,523,284 in 2025 from $13,465,499 in 2024.
• Equity increased by approximately 0.9% to $629,614,699 in 2025 from $623,966,840 in 2024.

Negatives

• Revenue from sales of laboratory testing kits decreased by approximately 41.2% to $143,575 in 2025 from $244,218 in 2024.
• Operating and administrative expenses increased by approximately 7.4% to $26,819,214 in 2025 from $24,964,324 in 2024.
• Cash and cash equivalents decreased significantly by approximately 84.0% to $61,031,110 as of December 31, 2025, from $382,110,455 as of December 31, 2024.
• Bank deposits with more than three months to maturity increased significantly by approximately 151.2% to $561,152,523 as of December 31, 2025, from $247,297,181 as of December 31, 2024, indicating a shift in asset allocation.

Risks

• The company's reliance on other income, particularly bank interest income, for profitability suggests potential vulnerability to changes in interest rates or investment strategies.
• The decrease in revenue from laboratory testing kits may indicate increased competition or reduced demand for these products.
• The significant decrease in cash and cash equivalents, coupled with a substantial increase in longer-term bank deposits, could indicate a strategic shift in liquidity management or potential future investment needs.
• The company is subject to foreign exchange risk, although it is currently considered minimal due to the HKD's peg to the USD and its close alignment with the RMB.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from management regarding future performance. However, the inclusion of separate financial statements for Insighta Holdings Limited suggests a focus on providing detailed financial transparency for its significant investments.

Industry Context

StockSavvy.ai notes that this filing is an amendment to Prenetics Global Limited's 20-F report, specifically to include the financial statements of its significant equity method investment, Insighta Holdings Limited. This indicates a focus on consolidating financial reporting for key subsidiaries or investees, a common practice for companies with complex ownership structures or significant strategic investments in other entities.

Related Party Transactions

• Consultancy and management service income of $468,000 was recognized in both 2025 and 2024.
• Sales and marketing service income of $420,916 was recognized in 2025, compared to $238,328 in 2024.
• An amount due to a related company was $2,274,399 as of December 31, 2025, down from $9,159,071 as of December 31, 2024.
• A waiver of an amount due to a related company of $3,591,998 was recognized in 2025.

Stakeholder Impact

• Shareholders may see a positive impact from the increased profitability, although the decrease in revenue from laboratory testing kits could be a concern.
• Creditors may be reassured by the significant reduction in total liabilities.
• Employees' impact is not directly detailed, but operational expenses have increased, which could reflect increased staffing or related costs.

Next Steps

• The filing serves to supplement the original Form 20-F with the financial statements of Insighta Holdings Limited.
• The company will continue to prepare and file its annual reports and other required disclosures with the SEC.

Key Dates

Recommendation

The filing shows improved profitability driven by non-operational factors and a reduction in liabilities, which is positive. However, a decline in a core revenue stream (laboratory testing kits) and the lack of specific forward-looking guidance warrant a cautious 'hold' recommendation until further clarity on the sustainability of the profit drivers and the strategy for the declining revenue segment is provided.

Keywords

Insighta Holdings Limited, Financial Statements, Form 20-F/A, Annual Report, Biotechnology, Diagnostics, Laboratory Testing Kits, IFRS, Hong Kong Dollars, Profit Before Tax, Comprehensive Income, Revenue, Other Income, Assets, Liabilities, Equity